34 Investors — «COVID-19 MedTech Industry Landscape by Region» | RadialReport

1. AIM ImmunoTech ¹⁹⁹⁰

2. Altimmune ¹⁹⁹⁷

3. Applied DNA Sciences ¹⁹⁸³

4. Arcturus Therapeutics ²⁰¹³

5. Athersys ¹⁹⁹⁵

6. BGI Genomics ¹⁹⁹⁹

7. Brii Biosciences ²⁰¹⁸

8. Butterfly Network ²⁰¹¹

9. Capricor Therapeutics ²⁰⁰⁵

10. Cipla ¹⁹³⁵

11. Cocrystal Pharma ²⁰⁰⁴

12. Eli Lilly

13. Emergent BioSolutions ¹⁹⁹⁸

14. Enanta Pharmaceuticals ¹⁹⁹⁸

15. Fosun Pharma ¹⁹⁹⁴

16. Generex Biotechnology ¹⁹⁸³

17. Grifols ¹⁹⁴⁰

18. Hoth Therapeutics ²⁰¹⁷

19. Innovation Pharmaceuticals ²⁰⁰⁷

20. Inovio Pharmaceuticals ¹⁹⁷⁹

21. Israel Aerospace Industries ¹⁹⁵³

22. LabCorp ¹⁹⁷⁸

23. Lattice Biologics ²⁰¹³

24. Moderna ²⁰¹⁰

25. Neurimmune Holding ²⁰⁰⁶

26. Novan ²⁰⁰⁸

27. PerkinElmer ¹⁹³¹

28. Pharmstandard ²⁰⁰³

29. Q BioMed ²⁰¹³

30. Roche Holding AG

31. Roivant Sciences ²⁰¹⁴

32. Sorrento Therapeutics ²⁰⁰⁶

33. Teva Pharmaceuticals ⁰

34. Windtree Therapeutics ¹⁹⁹²

«COVID-19 MedTech Industry Landscape by Region»

— investor and funding support bodies
— hubs and other organisation types

Industries

Aerospace, Infrastructure, Manufacturing, Military, National Security, Navigation

Biotechnology, Data and Analytics, Health Care, Science and Engineering

Biotechnology, Health Care, Professional Services, Science and Engineering

Investment Funds

test_custom_domain_2

© 2025